Safety & Contraindications

Class IV laser therapy has an excellent safety profile when administered by trained professionals following established guidelines. The FDA-cleared designation reflects this record. Serious adverse events are extremely rare.

Standard Safety Precautions

  • Protective eyewear is mandatory for all individuals in the treatment room — both patient and clinician. Wavelength-specific, optical-density–certified goggles must match the laser's operating wavelength. Direct ocular exposure to a Class IV laser beam can cause permanent retinal damage.

  • Lasers should be kept in continuous motion during treatment to prevent thermal concentration at any single point.

  • The treatment area should be designated as a controlled zone during laser operation

  • All operators should have completed formal laser safety training.

Common (Mild and Transient) Side Effects

  • Mild warmth or tingling at the treatment site — normal and expected.

  • Temporary skin redness (erythema) that resolves within hours.

  • Brief post-treatment sensitivity in highly inflamed tissue (resolves in 24–48 hours)

  • Rare cases of minor skin irritation if laser is held stationary too long.

Serious side effects such as burns are completely avoidable with proper technique and training.

Absolute Contraindications

The following represent situations where Class IV laser therapy must not be applied due to known risk of harm:

Relative Contraindications (Use Clinical Judgment)

Contraindication

Rationale

Direct eye exposure

Risk of permanent retinal and corneal damage

Over active cancer or malignant tumors

Risk of biostimulative promotion of tumor growth

Over a gravid (pregnant) uterus

Risk of adverse effects on fetal development


These conditions require careful consideration and, in some cases, modification of treatment parameters:

  • Patients taking photosensitizing medications (some steroids, antibiotics, NSAIDs)

  • Patients with active systemic infections (potential biostimulation of pathogens)

  • Immunocompromised patients (e.g., HIV/AIDS, organ transplant recipients)

  • Severe collagen vascular diseases (e.g., systemic lupus erythematosus)

  • Over tattoos — dark pigment absorbs laser energy rapidly, increasing thermal risk

  • Patients on anticoagulant therapy (increased bruising risk)

  • Dark skin with high-power red wavelength lasers (monitor for thermal effects)

  • Over pacemakers or implanted pain pumps (direct overlap contraindicated; treatment in surrounding tissue is appropriate)

  • Renal failure / dialysis patients (risk of nausea from vasodilation and toxin release)

  • Children: avoid over open growth plates (epiphyseal plates)

Pregnancy

Laser therapy is contraindicated over the abdominal region and low back/pelvic area in pregnant patients. Treatment of other body regions in pregnant patients is generally considered appropriate and safe.


Valerie Krossin

As a nurse and educator with over 16 years of experience in the field of photobiomodulation (PBM), I have witnessed firsthand the transformative impact of this innovative therapy on pain, healing and sports recovery and performance enhancement. As the Educational Director and Senior Account Manager for industry leaders ASPEN Laser and TheraLight, I have been instrumental in forming strategic alliances with health professionals, businesses, individuals and professional and collegiate teams.

PBM harnesses the power of specific wavelengths of light, particularly in the red and near-infrared spectrum, to stimulate cellular processes such as ATP production, enhance mitochondrial function, reduce inflammation, promote tissue repair, and modulate biological responses like gene expression and ion channel activity. These benefits make near-infrared light a versatile tool in PBM, with applications ranging from athlete recovery and performance improvement and pain management to potential treatments for complex neurological conditions.

My unique perspective, combining over two decades of nursing experience with expertise in cutting-edge PBM technology, has allowed me to bridge the gap between clinical practice and sports medicine. This is evident in my recent work, including an abstract accepted by the American Society for Laser Medicine and Surgery (ASLMS) for E-Poster Presentation on Transcranial PBM for treating neurodegenerative diseases.

As the field of PBM continues to evolve, I remain committed to advancing its science and application in sports medicine. We are opening new frontiers in athletic performance and recovery, providing athletes with safe, effective, and non-invasive methods to optimize their potential.

https://www.photobiomodulation.expert
Previous
Previous

Protocol Recommendations

Next
Next

Research & Evidence